This clinincal-stage biopharmaceutical company provider has seen no estimate revisions in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same time frame. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rockwell Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the medical products industry are GW Pharmaceuticals plc (GWPH), ICU Medical, Inc. (ICUI) and Abaxis, Inc. (ABAX). While GW Pharmaceuticals sports a Zacks Rank #1 (Strong Buy), ICU Medical and Abaxis carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment